DuPont de Nemours, Inc. DD

Healthcare SIC 2821 - Plastic Materials, Synth Resins & Nonvulcan Elastomers NAICS Manufacturing › Chemical Manufacturing › Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing › Resin and Synthetic Rubber Manufacturing › Plastics Material and Resin Manufacturing derived NYSE

Throughout this Annual Report on Form 10-K, except as otherwise noted by the context, the terms "DuPont" or "Company" used herein mean DuPont de Nemours, Inc. and its consolidated subsidiaries.

DuPont is a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. The Company is committed to helping customers advance their technology pipelines and provide solutions that address their unique challenges. From delivering clean water to enabling medical packaging solutions which enhance safety and performance, DuPont's innovations power the essential products and technologies people rely on every day. At December 31, 2025, the Company has subsidiaries in about 50 countries worldwide and manufacturing operations in about 20 countries. See Note 23 to the Consolidated Financial Statements for details on the location of the Company's sales and property.

Last close 136.55 2026-10-23
Market cap $18.44B 2026-06-30 share count
52-week range 100.00 - 157.98

Valuation FY2025 figures against the last close

P/S2.7x
P/E—
P/FCF81.2x
EV/EBITDA—
Dividend yield3.2%
Diluted EPS-1.86

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $6.85B$6.72B$6.61B$13.02B$12.57B$11.13B$15.44B$16.38B$11.67B$48.16B
Cost of revenue $4.49B$4.50B$4.44B$8.40B$7.97B$7.06B$10.03B$11.12B$9.56B$37.67B
Gross profit $2.36B$2.22B$2.17B$4.62B$4.59B$4.07B$5.41B$20.64B$12.69B$10.52B
R&D $193.0M$203.0M$192.0M$536.0M$557.0M$565.0M$689.0M$797.0M$657.0M$1.59B
SG&A $1.02B$976.0M$891.0M$1.47B$1.60B$1.49B$2.06B$2.40B$1.61B$2.95B
Pre-tax income $200.0M$117.0M-$279.0M$1.45B$1.44B-$1.26B-$126.0M-$135.0M-$1.52B$4.41B
Income tax $102.0M$213.0M$217.0M$387.0M$237.0M$90.0M$2.0M$50.0M$1.76B$9.0M
Net income $88.0M$703.0M$423.0M$5.87B$6.47B-$2.95B$498.0M$3.85B$1.16B$4.32B
EPS, basic -1.871.680.9411.7711.92-4.010.674.992.183.57
EPS, diluted -1.861.680.9411.7511.89-4.010.674.992.153.52
Shares, diluted (wtd. avg.) 419.2M419.2M449.9M499.4M544.2M735.5M746.3M767.0M532.7M1.12B

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $715.0M$1.79B$2.75B$3.72B$2.04B$8.73B$1.52B$8.58B$14.02B$6.62B
Short-term investments ——$0$1.30B$0—$0$29.0M$956.0M$0
Receivables $910.0M$789.0M$1.51B$1.57B$1.61B$1.85B$2.95B$2.89B$11.31B$4.67B
Inventory $1.17B$1.13B$2.15B$2.33B$2.09B$2.39B$4.32B$4.11B$16.99B$7.36B
Total current assets $5.58B$20.77B$7.51B$11.27B$14.30B$29.01B$10.00B$126.66B$49.89B$23.66B
Property, plant and equipment —————$9.98B$10.14B$9.92B$36.25B$23.49B
Goodwill $7.92B$7.56B$7.66B$16.66B$16.98B$16.04B$22.14B$34.50B$34.82B$15.27B
Other intangibles $2.94B$3.18B$5.81B$5.50B$6.22B$8.07B$13.59B$14.65B$33.27B$6.03B
Total assets $21.57B$36.64B$38.55B$41.35B$45.71B$70.90B$69.35B$187.85B$191.91B$79.51B
Accounts payable $995.0M$1.05B$1.68B$2.10B$2.10B$2.22B$2.93B$2.62B——
Short-term debt $0$1.85B$0$300.0M$150.0M$1.0M$3.83B$15.0M$1.95B$272.0M
Total current liabilities $2.31B$5.50B$3.10B$3.73B$4.93B$12.23B$8.35B$73.31B$26.13B$12.60B
Long-term debt ——$7.86B$8.14B$10.63B$15.61B-$15.62B-$12.63B$32.12B$21.09B
Total liabilities $7.47B$12.84B$13.83B$14.34B$18.66B$31.83B$27.79B$91.95B——
Retained earnings -$24.28B-$23.08B-$22.87B-$21.07B-$23.19B-$11.59B-$8.40B$30.26B$29.21B$30.34B
Total equity $13.92B$23.35B$24.73B$27.02B$27.05B$39.07B$41.56B$95.90B$101.65B$27.25B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $560.0M$765.0M$845.0M$1.25B$1.85B$4.09B$1.41B$4.73B-$765.0M-$2.96B
Depreciation and amortisation $647.0M$635.0M$580.0M$1.14B$1.11B$3.09B$3.19B$1.54B$1.06B$2.86B
Stock-based compensation $38.0M$56.0M$57.0M$75.0M——————
Capital expenditure $333.0M$285.0M$302.0M$662.0M$788.0M$1.19B$2.47B$1.24B$551.0M$3.80B
Investing cash flow -$374.0M-$562.0M$481.0M$9.00B-$2.30B-$202.0M-$2.31B-$2.46B$14.32B$5.09B
Financing cash flow -$1.75B-$1.83B-$2.96B-$7.65B-$7.59B$3.24B-$11.55B-$1.92B-$6.55B-$4.01B
Dividends paid $597.0M$635.0M$651.0M$652.0M$630.0M$882.0M$1.61B$3.49B$3.39B$2.46B
Buybacks $400.0M$400.0M$1.60B$3.73B$2.14B$232.0M$2.33B$4.42B$1.00B$916.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-151204.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -20B 0 20B 40B 60B Revenue, FY2016: 48.2B Gross profit, FY2016: 10.5B Net income, FY2016: 4.3B Revenue, FY2017: 11.7B Gross profit, FY2017: 12.7B Net income, FY2017: 1.2B Revenue, FY2018: 16.4B Gross profit, FY2018: 20.6B Net income, FY2018: 3.8B Revenue, FY2019: 15.4B Gross profit, FY2019: 5.4B Net income, FY2019: 498M Revenue, FY2020: 11.1B Gross profit, FY2020: 4.1B Net income, FY2020: -3B Revenue, FY2021: 12.6B Gross profit, FY2021: 4.6B Net income, FY2021: 6.5B Revenue, FY2022: 13B Gross profit, FY2022: 4.6B Net income, FY2022: 5.9B Revenue, FY2023: 6.6B Gross profit, FY2023: 2.2B Net income, FY2023: 423M Revenue, FY2024: 6.7B Gross profit, FY2024: 2.2B Net income, FY2024: 703M Revenue, FY2025: 6.8B Gross profit, FY2025: 2.4B Net income, FY2025: 88M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $48.16B $11.67B $16.38B $15.44B $11.13B $12.57B $13.02B $6.61B $6.72B $6.85B
Gross profit $10.52B $12.69B $20.64B $5.41B $4.07B $4.59B $4.62B $2.17B $2.22B $2.36B
Net income $4.32B $1.16B $3.85B $498.0M -$2.95B $6.47B $5.87B $423.0M $703.0M $88.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2821

TickerCompanyMarket capP/ERevenue growth
DOW DOW INC. $23.50B — -7.0%
ALB ALBEMARLE CORP $11.05B — -4.4%
EMN EASTMAN CHEMICAL CO $7.43B 15.8x -6.7%
HXL HEXCEL CORP /DE/ $6.02B — -0.5%
AVNT AVIENT CORP $3.76B 46.1x 0.6%
ROG ROGERS CORP $2.23B — -2.3%
PCT PureCycle Technologies, Inc. $556.5M — —
ASIX AdvanSix Inc. $424.2M 8.7x 0.3%